Lv51
1210 积分 2024-03-22 加入
The global burden of IBD: from 2015 to 2025
1小时前
待确认
Inflammatory bowel disease burden in China and the United States from 1990–2023 and prediction to 2050
2天前
已完结
Organization and outcomes of multidisciplinary intestinal failure teams
9天前
已完结
Management of acute intestinal failure: A position paper from the European Society for Clinical Nutrition and Metabolism (ESPEN) Special Interest Group
9天前
已完结
Trends in the drug target landscape for autoimmune diseases
10天前
已完结
Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery
10天前
已完结
Decreased ER visits and readmissions after implementation of a standardized perioperative toolkit for children with IBD
23天前
已完结
Impact of Clinical Pharmacists in the Inflammatory Bowel Disease Clinic
23天前
已完结
Treatment and Outcomes of Crohn’s Disease and Ulcerative Colitis in Newly Diagnosed Adults in the United States, 2007-23
24天前
已关闭
Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial
25天前
已完结
皖公网安备34019202002308
